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Oligoclonal bands and increased IgG antibody levels can be detected in the cerebrospinal 
fluid in vast majority of patients with Multiple Sclerosis (MS). However, the antigenic 
specificity of oligoclonal IgG has yet to be determined. Using laser capture microdissection, 
we isolated single CD38+ plasma cells from lesion areas in two autopsy MS brains, and 
generated three recombinant antibodies (rAbs) from clonally expanded plasma cells. Panning 
phage-displayed random peptide libraries was carried out to determine peptide antigen 
specificities of these MS brain rAbs. We identified 25 high affinity phage peptides from 
which 5 peptides are unique. Database searches revealed that they shared sequence 
homologies with Epstein-Barr nuclear antigens 4 and 6, as well as with other viral proteins. 
Significantly, these peptides were recognized by intrathecal IgG and oligoclonal IgG bands in 
other MS patients. Our results demonstrate that functional recombinant antibodies can be 
generated from clonally expanded plasma cells in MS brain lesions by laser capture 
microdissection, and that these MS brain rAbs have the potential for determining the targets 



















Multiple Sclerosis (MS) is a chronic demyelinating disease of the central nervous system 
(CNS) which is a major cause of neurological disability, especially in young adults, in 
northern temperate zones (Gilden, 2005, Kennedy and Steiner, 1994). Typical immunological 
features in MS patients include the presence of clonally expanded B-lymphocytes and plasma 
cells in the cerebrospinal fluid (CSF), an increase in CSF IgG, and the presence of 
oligoclonal bands in over 90% of cases (Owens et al. , 2003, Reiber et al. , 1998, Yu et al. , 
2011a). While oligoclonal bands are known to be directed against specific pathogens in a 
number of chronic neurological infections such as subacute sclerosing panencephalitis 
(SSPE), cryptococcal meningitis, neuroborreliosis and neurosyphilis (Gilden, 2005), the 
antigenic specificity of oligoclonal IgG in MS, despite its critical importance in disease 
activities (Ferreira et al. , 2014, Joseph et al. , 2009), has so far proved to be elusive (Owens 
et al. , 2009). Our recent publication suggested that there is a complex relationship between 
oligoclonal bands and immunoglobulin G antibodies in MS (Beseler et al. , 2017).  
 
By screening phage-displayed random peptide libraries with recombinant antibodies 
generated from clonally expanded B cells in MS CSF, we have demonstrated that high 
affinity linear peptides can be identified (Yu et al. , 2011b, Yu et al. , 2006b). Furthermore, 
we showed that peptides selected by MS CSF were recognized by intrathecal IgG antibodies 
in MS patients over time, and that the peptides can be used to investigate the disease 
progression (Yu, Burgoon, 2011a). In addition, we recently reported that in MS the number 
of oligoclonal IgG bands has no relationship with the concentration of CSF IgG (Beseler, 
Vollmer, 2017), suggesting that the increased IgG in MS may be represented by IgG-
containing immune complexes. Phage-displayed random peptide libraries provide a unique 
unbiased approach to identify high affinity targets regardless of previous knowledge.  
 
We herein report the generation of recombinant antibodies derived from laser captured single 
plasma cells of MS brain lesions, and results of using these antibodies to determine which, if 
any, peptide antigens are specific to the intrathecal MS antibody response (Yu, Gilden, 
2011b). Laser-capture microdissection (LCM) of clonally expanded plasma cells from 
Subacute sclerosing panencephalitis (SSPE) brain originally showed that overrepresented IgG 
sequences could be used to produce functional recombinant antibodies (rAbs) capable of 
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recognising specific disease-related antigens (Burgoon et al. , 2005). Subsequent studies used 
19 rAbs generated from such clonally expanded B cells and native IgG from the CSF of 3 MS 
patients, combined with the technique of panning with phage displayed random peptide 
libraries, to show antibody-peptide interactions shared by the rAbs and IgG obtained from the 
same MS patient (Yu, Burgoon, 2011a). Further, the same technological approach showed 
that the panned phage peptides bound specifically to IgG in the CSF of 5 MS patients over 
time (longitudinal sampling) (Yu, Burgoon, 2011a). This was significant because CSF 
oligoclonal IgG persists throughout the lifetime of MS patients (Petereit and Reske, 2005).  In 
the present work, we generated MS brain recombinant antibodies from laser captured 
microdissection of clonally expanded single plasma cells and identified high affinity phage 
peptides using a similar panning approach. We have extended the range of the possible 
antigenic specificity of CSF IgG in MS by showing that phage peptides selected by MS 
brain-derived rAbs are recognized by intrathecal IgG and oligoclonal bands of other unrelated 
MS patients. 
 
2. Materials and Methods 
2.1. Generation of MS brain derived recombinant antibodies from single plasma cells by 
laser capture microdissection 
 
Using established techniques for single-cell laser capture microdissection (LCM) (Burgoon, 
Keays, 2005), single CD38-positive plasma cells were isolated from multiple lesion areas of 
frozen autopsied samples from two MS brains. One brain (MS brain A: ST) was from the 
autopsy of a relapsing remitting MS (RRMS) patient. The second brain (MS brain B: G2) was 
from the autopsy of a secondary progressive MS (SPMS) patient, and which was reported 
previously to have meningeal follicles and EBV-infected B cells (Serafini et al. , 2004). Each 
brain sample contained expanded numbers of CD20-positive B lymphocytes and CD38-
positive plasma cells compared to control non-MS brain samples. Laser capture 
microdissection and following IgG heavy and light chain variable sequence amplification 
were performed on 40-50 individually micro-dissected plasma cells for each brain. The 
construction and generation of the recombinant antibodies (rAbs) utilized techniques as 
previously described (Burgoon, Keays, 2005).  
Briefly, CD38+ plasma cells were identified by staining and micro dissected from 12 µm 
brain sections onto individual caps. Cells were lysed with NP-40 and reverse-transcription 
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performed on cap surfaces. Heavy chain and light chain antibody sequences were PCR-
amplified from each CD38+ cell, and subcloned into TA vector for sequencing. The selected 
pairs of heavy and light chain IgG sequences were subcloned into mammalian expression 
vectors and transfected into HEK293-EBNA cells, and secreted human recombinant 
antibodies (rAb) contained a flag epitope, were purified by Protein A affinity 
chromatography. The recombinant antibodies are named as A1 (ST-176), A2 (ST-196), and 
B1 (G2-160).  
 
2.2. Biopanning, phage titration and amplification 
 
The Phage Display Peptide Libraries (12mer + 7mer) (New England BioLabs, Beverly, MA) 
were used for affinity selection of specific peptides for the MS brain rAbs. The panning 
procedure was essentially as described (Yu et al. , 2006a). MS brain rAbs at a concentration 
of 150 μg/ml were added to wells of Reacti-Bind™ Protein A-coated clear strip plates 
(Thermo Scientific, Rockford, IL) in 50 μl Tris-buffed saline (TBS) and incubated overnight 
at 4°C. After blocking, the phage peptide library (1.5×1010 pfu) in 100 μl of TBST (TBS-
0.5% Tween 20) was added to the wells and incubated for 1 h at room temperature. Elution of 
bound phage was performed at either room temperature for 20 min or at 37°C for 10 min (Yu 
et al. , 2009). Three to five rounds of panning were carried out. The affinity-selected phage 
were titered after each rounds of panning. Phage titering and amplification was as described 
(Yu, Gilden, 2006a).  
 
2.3. Single-point 96 well ELISA  
 
Primary single-point 96 well ELISA was carried out as reported (Yu, Owens, 2006b). 
Individual plaques selected by each antibody from the titer plates of second and third pans or 
higher pans were picked and placed into wells of U96 DeepWell™ plates (Nunc 
International, Rochester, NY) containing 500 μl of a 1:10 dilution of optical density = 1.0 or 
1:100 dilution of overnight culture of E. coli ER 2738 in LB medium. The plate was covered 
with breathable sealing tape (NUNC). After 4.5 h of infection at 37 °C at 250 rpm, the 
DeepWell plates were centrifuged at 4,000 rpm for 10 min at 4 °C in a Sorvall RT 6000 
refrigerated centrifuge. The supernatants containing amplified phage were transferred to a 
new DeepWell plate and stored at 4°C. For primary fast screening of potential positive phage, 
a microtiter plate (Corning, Corning, NY) was coated with 50 μl of MS brain rAbs in 0.1 M 
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carbonate buffer, pH 9.5 at 1 μg/ml, blocked with 3% BSA for 1 h and washed with TBST 
three times. Phage supernatants (50 μl) from the DeepWell plate were added directly to 
individual wells and incubated for 1 h with shaking at room temperature. Plates were washed 
with TBST 10 times for 1 min each time, followed by incubation with 50 μl of 1:500 dilution 
of horseradish peroxidase (HRP)/anti-M13 antibody conjugate (New England Biolabs) in 1% 
BSA/Tween20 for 1 h. The plates were washed 8 times with TBST. Bound phage were 
detected using HRP substrate ABTS (Vector Laboratories, Burlingame, CA). After 
incubation with substrate for 20-30 min, absorbance at 405 nm was determined 
spectrophotometrically with a Microplate Reader (Bio-Rad, Hercules, CA).  
 
2.4. ELISA determining phage binding specificity 
 
To confirm positive phage results from single-point 96-well ELISA, MS brain rAb (50 μl at 1 
μg/ml) with human IgG antibody as negative control was coated in duplicate in wells of an 
ELISA plate overnight at 4 °C. Wells were blocked with 3% BSA for 1 h and 5×109 
corresponding phage were added to each well. After washing, bound phage were detected as 
described above. For dose-response ELISA, serial 2-fold phage dilutions were added to wells 
coated with respective panning MS brain rAb and a human IgG as negative control. Phage 
detection was as described above. ELISA was repeated at least once. 
 
2.5. Dose–response phage-mediated immuno-PCR (IPCR) 
 
Phage-mediated IPCR was performed as described (Yu et al. , 2007). Reacti-Bind™ wells of 
protein A-coated clear strip plates (Thermo Scientific, Rockford, IL) were coated with 50 μl 
of CSF or serum (1 μg/ml IgG) and with pre-immune human IgG (Alpha Diagnostic) in TBS 
(50 mM Tris–HCl, 150 mM NaCl) at room temperature for 2 h, washed with TBS containing 
0.05% Tween20 (TBST) and blocked in 3% non-fat dry milk/0.05% TBST at room 
temperature for 1 h. Serial 10-fold phage dilutions in duplicate were added to MS CSF/serum 
IgG-coated wells and incubated at room temperature for 2 h. Bound phage were lysed in 50 
μl of double-deionized water by heating the plates at 95 °C for 15 min to release single-
stranded phage DNA as the template for real-time PCR in an Applied Biosystems 7500 Fast 
Real-Time PCR system (Applied Biosystems, Foster City, CA). For standard SYBR® Green 
PCR, each reaction (20 μl) consisted of 1× power SYBR® Green master mix (Applied 
Biosystems), 750 nM of each M13 phage primer and 4 μl of phage template. Thermal cycle 
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conditions were 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 45 s. 
Fast real-time PCR was conducted using 1× Fast SYBR® Green master mix, with thermal 
cycling at 95 °C for 20 s, followed by 40 cycles at 95 °C for 3 s and 60 °C for 30 s. A control 
reaction without template was included in each run. 
 
2.6. Western blots  
 
NuPAGE Bis-Tris Mini Gels (Invitrogen, Carlsbad, CA) were used for phage SDS-PAGE 
analysis with 1X MOPS SDS Running Buffer. Phage peptides (1×1011/well) in TBS were 
denatured and reduced with 1X protein sample buffer containing β mercaptoethanol (Pierce 
Biotechnology, Rockford, IL) at 95°C for 10 min. Duplicate gels were eletrophoresed for 50 
min under constant voltage of 200 V. The gel was then electroblotted onto a PVDF 
membrane (Bio-Rad) for 60 min under constant voltage of 15 V using Trans-Blot® Semi-Dry 
Cell (Bio-Rad). After blocking with 1X casein/TBS (Vector Laboratories) containing 0.1% 
Tween 20 for 1 h, the membrane was incubated with corresponding MS brain rAb (1 μg/ml) 
for 1 h in 1X casein/TBS buffer with 0.1% Tween20. Peroxidase conjugated goat anti-human 
IgG (H+L) (Sigma, St. Louis, MO) at a dilution of 1:5000 was used to detect rAb binding to 
phage. After incubation with each antibody, membranes were washed once with TBST for 15 
min, then four more times for 5 min each. The membrane was incubated with SuperSignal® 
West Femto Maximum Sensitivity chemiluminescent substrate (Pierce) as recommended by 
the manufacturer. For detection of phage pIII protein, duplicate membranes were incubated 
with a 1:25,000 dilution of anti-M13 pIII monoclonal antibody (New England BioLabs). A 
1:25,000 dilution of goat anti-mouse IgG peroxidase conjugate (Vector Laboratories) was 
used as secondary antibody followed by chemiluminescent detection as described (Yu, 
Burgoon, 2011a). 
 
2.7. Isoelectric focusing (IEF) immunoblotting 
 
IEF immunoblotting was as described (Yu, Burgoon, 2011a). CSF (200–500 μl) was 
centrifuged on an Amicon Ultra 0.5-ml 30 K cellulose centrifugal filter unit at 14,000×g for 
30 min at room temperature before IEF using the SPIFE® IgG IEF kit (Helena Laboratories, 
Beaumont, TX) and a SPIFE 3000 electrophoresis analyzer. Wicks were soaked in an anode 
(0.3 M acetic acid) or cathode (1 M NaOH) solution and applied to the edge of a SPIFE® 
IgG IEF gel. Five microliters of MS CSF/sera [3–5 μg IgG for phage probe and 100 ng IgG 
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for alkaline phosphatase (AP)-conjugated anti-human IgG probe] were loaded into wells of 
an SPIFE IEF gel. After electrophoresis at 700 V for 1 h at 15 °C, samples were transferred 
to PVDF membranes for 45 min, followed by blocking in Helena blocking agent (1 g bovine 
milk protein/50 ml 1× TBS) for 1 h at room temperature. Membranes were incubated with the 
respective phage peptide at concentrations ranging from 5.0×1010 to 1.5×1011 pfu/ml in 1:10 
Helena blocking agent/TBST (blocking buffer) at room temperature for 2 h. After washing 
with 0.05% Tween-TBS, membranes were incubated with mouse anti-M13 mAb at a 1:500 
dilution in blocking buffer, followed by incubation with 1:500 dilution of AP conjugated anti-
mouse IgG at room temperature for 1 h. Membranes were developed with NBT/BCIP 
substrate. For control blots, membranes were incubated for 1 h with 1:1000 dilutions of AP-
anti-human IgG (H+L) in blocking buffer, followed by NBT/BCIP detection. 
 
2.8. DNA sequencing and peptide database search 
 
Single-stranded phage DNA was purified and sequenced to deduce the amino acid sequence 
of the peptide. All DNA sequencing was performed at the University of Colorado Cancer 
Centre Genomics and Microarray Shared Resource. Peptide sequences were deduced from 
DNA sequences. Consensus peptides were identified by sequence alignment using Clustal 
Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/). For identifying candidate proteins, each 
peptide was used for the database search in BLAST (http://www.ncbi.nlm.nih.gov/) using 
Swiss-Prot protein sequences database.  
                                            
                                       
3. Results 
  
3.1. Generation of recombinant antibodies from clonally expanded single plasma cells by 
laser captured microdissection of MS plaques  
 
The three MS brain rAbs used in this study were generated from clonal expanded CD38+ 
plasma cells isolated by single-cell laser microdissection from lesional areas of 2 MS brains 
(Burgoon, Keays, 2005). Each of the brain rAbs were from the sequences of expanded 
plasma populations (30-50 plasma cells) of the corresponding lesional tissues. One plaque 
tissue was from a RRMS brain (A, ST), and the other was from a SPMS brain (B, G2). 
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Sequences of both the IgG heavy and light chain V regions were determined for populations 
of (CD38-positive) plasma cells after RNA isolation and RT-PCR.  Multiple areas from each 
brain expressed repertoires of clonally expanded IgG sequences (data not shown). The CDR3 
sequences of several expanded clones are shown in Table 1. The VH and VL CDR3 amino 
acid sequences, the closest germline segment, and the degree of homology are shown. Two 
rAbs were generated from MS Brain A named MS-A1 (ST-176), and MS-A2 (ST-196), and 
one rAb was generated from MS Brain B named MS-B1 (G2-160). It can be seen that the 
homology was always high (overall 87.5%-97.1%) with the greatest homology shown by 
brain rAb MS-A1 (ST-176), and the lowest by brain rAb MS-B1 (G2-160) that show 
comparative somatic mutation from germline Ig alleles.  
 
3.2. High affinity phage peptides that reacted with MS brain rAbs were identified by panning 
phage displayed random peptide libraries 
 
Three MS brain rAbs generated from clonally expanded plasma cells by LCM were studied 
for antigen specificity by panning combined phage-displayed random peptide libraries (Ph.D. 
12 + Ph.D. 7, 12-mers and 7-mers). Phage panning procedures were as described previously 
(Yu, Gilden, 2006a). A total of 5 pans were performed. We applied a high throughput 
approach for fast screening of phage peptides which were specific to panning MS brain rAbs 
using a streamlined protocol (Yu, Owens, 2006b). We identified 25 high affinity phage 
peptides by the 3 MS brain rAbs from which 5 peptides are unique. MS brain rAb A1 (ST-
176) identified 2 unique peptides, MS brain rAb A2 (ST-196) identified 2 unique peptides, 
and MS rAb B1 (G2-160) selected one unique peptide. We named the peptides based on the 
rAb used for panning. For example, phage peptide A2 (ST-196) D2 represents peptide D2 
selected by MS rAb A2 (ST-196). We performed sequence alignment analysis and no 
common antigens were found (data not shown). The results of peptide sequences are listed in 
Table 2. Database searches revealed that they shared sequence homologies with Epstein-Barr 
nuclear antigens 4 and 6, as well as with other viral proteins. In addition, these peptides show 
high sequence homologies with human proteins such as TRPM8 channel-associated factor 2, 
G-protein coupled receptor, and ubiquitin-like modifier-activating enzyme. Table 3 lists 
candidate proteins of the BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) 





3.3. Binding specificities of selected phage peptides by MS brain recombinant antibodies 
 
ELISA was used to determine phage peptide binding specificities to panning MS brain rAbs 
(Yu, Gilden, 2006a). The results of these experiments are shown in Figure 1. It can be seen in 
Fig 1A that phage peptides selected by MS brain rAb A1(ST-176) have higher bindings to the 
panning MS brain rAb A1 (ST-176) but less to control human IgG. Fig. 1B shows that all 
phage clones selected bind specifically to the panning MS rAb A2 (ST-196) but not to control 
human IgG. In Fig 1C, we show the cross reactivity of selected phage peptides to non-
panning brain rAbs. It can be seen that phage peptides A1 (ST-176) C3 and A1 (ST-176) B1 
identified by brain rAb A1 (ST-176) bind to panning rAb A1 (ST-176) as well as to non-
panning rAb A2 (ST-196) and control human IgG, suggesting that these peptides were poly-
specific. Peptides A2 (ST-196) F4 and A2 (ST-196) D2 identified by MS brain rAb A2 (ST-
196) were specific only to panning MS rAb A2 (ST-196), but not to non-panning rAb A1 
(ST-176) and control human IgG, suggesting these peptides were specific. We further 
characterized phage peptides A2 (ST-196) D2 and F4 (selected by MS brain rAb A2) with 
dose-response ELISA as shown in Fig. 1D. Both peptides bind to panning MS brain rAb A2 
(ST-196) in a dose-responsive manner.  
 
To further characterize these MS brain rAb specific peptides, we carried out Western blot 
analysis. Representative phage panned by 2 brain rAbs were separated on a gradient of 4-
12% SDS polyacrylamide gel under reducing and denaturing conditions, blotted to a PVDF 
membrane and incubated with corresponding brain rAbs. Phage peptides A2 (ST-196) F6, A2 
(ST-196) C3, and B1 (G2-160) D2, B1 (G2-160) F2 were recognized by corresponding 
panning MS brain rAb A2 (ST-196) and B1 (G2-160), suggesting that these peptides were 
linear in conformation. Positive control was phage blot probed with anti-pIII antibody (Fig. 
2).  
 
3.4. Phage peptides selected by MS brain rAb were recognized by intrathecal IgG from MS 
patients 
 
To determine whether the MS brain rAb-selected peptides can be recognized by CSF IgG 
from other MS patients, we used highly sensitive and specific phage mediated immuno-PCR 
(IPCR) (Yu, Burgoon, 2007) and screened 18 paired CSF and sera from MS patients. Here, 
we coated plates with MS patient CSF, the corresponding patient serum, or with control 
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human IgG (at IgG concentration of 1µg/ml) to Protein A plates. MS brain rAb-selected 
phage were incubated with the coated IgG; bound phage were lysed and used as template 
DNA for IPCR. The lower the Ct value, the more phage were bound, presumably due to 
higher affinity for the Ab. Most of the MS IgG did not show positivises (data not shown). 
However, we show that phage peptides A2 (ST-196) C3 and A2 (ST-196) F4 are specific to 
intrathecal IgG of one MS CSF (MS03-4) but not to paired serum or human IgG controls 
(Fig. 3, A, C). The specificity of the intrathecal binding of MS brain rAb-selected phage 
peptides was further demonstrated that those phage peptides did not bind with differential 
affinity to an inflammatory control (chronic progressive meningoencephalitis) CSF, serum or 
human IgG (Fig. 3, B, D).  
 
To demonstrate that MS brain rAb-selected phage peptides were recognised by oligoclonal 
IgG from this MS patient (MS 03-4), we carried out IEF immunoblots (Graner et al. , 2020, 
Yu, Burgoon, 2011a). Paired CSF and serum from MS patient and MS brain rAb A2 (ST 
196) were resolved on agarose IEF gels and transferred to nitrocellulose membranes. The 
blots were probed with corresponding phage peptide A2 (ST-196) F4 followed by incubation 
with mouse anti-pIII antibody. A duplicate blot was probed with anti-human IgG as a positive 
control to reveal total oligoclonal bands. The phage peptide selected by MS brain rAb A2 
(ST-196) was recognized by multiple high-density oligoclonal IgG bands in the serum, but a 
weaker and reduced number of bands in the paired CSF (Fig. 4).  
                                        
4. Discussion  
Despite the very high frequency and unquestioned importance of CSF oligoclonal IgG bands 
in MS patients, the antigenic specificity of this IgG has yet to be determined. The presence of 
these IgG bands has been shown to be associated with significant clinical features such as a 
higher level of MS disability and disease activity (Joseph, Hirst, 2009), an increased risk of a 
second attack of MS (Tintore et al. , 2008), and a greater conversion rate of a clinically 
isolated syndrome to the relapsing and remitting form of the disease (Calabrese et al. , 2012). 
Conversely, less severe disease is associated with absent or few oligoclonal bands in the CSF 
(Avasarala et al. , 2001). Thus, it is difficult to conceive that these bands represent an 
epiphenomenon and are not a significant disease marker and/or factor in its 
neuropathogenesis. Our recent publication suggests that oligoclonal IgG antibodies in MS 




The approach adopted here is predicated on the importance of B-cell immunity in MS 
(Greenfield and Hauser, 2018) which is well accepted. Therefore, it was logical to focus on 
the antigenic specificity of MS brain-derived recombinant antibodies that were generated 
from individual clonally expanded plasma cells obtained from these brains by laser capture 
microdissection. The technique of panning phage displayed random peptide libraries to 
identify possible antigenic targets of the MS antibody response has been reported (Archelos 
et al. , 1998, Cortese et al. , 1996). Early studies demonstrated that recombinant antibodies 
derived from clonally expanded plasma cells of SSPE brains recognise their target antigens; 
the majority of tested rAbs bind specifically to the cause of disease, measles virus (Burgoon 
et al. , 2006, Burgoon, Keays, 2005, Owens et al. , 2007). The results of the current study 
have extended the previous studies which used phage displayed random peptide libraries to 
interrogate the possible binding targets of rAbs derived from single B cells of MS CSF (Yu, 
Gilden, 2011b, Yu, Gilden, 2006a). Using phage display library approach, we previously 
found that MS rAbs generated from clonal expanded single B cells of MS CSF, recognised 
specific peptides representing potential candidate protein antigens (Yu, Burgoon, 2011a). 
Further, we found that phage peptides bound specifically to IgG in MS CSF collected over 
time (Yu, Burgoon, 2011a). In the current study we adopted a more direct strategy using MS 
rAbs generated from clonally expanded single plasma cell clones obtained from MS brain 
lesions with well-developed laser capture microdissection techniques (Burgoon, Caldas, 
2006, Owens, Ritchie, 2007). 
 
We generated three MS brain rAbs from expanded plasma cell sequences in two MS brains: 
two rAbs from MS Brain A, MS rAb A1 (ST-176), and MS rAb A2 (ST-196), and one rAb 
from MS Brain B, MS rAb B1 (G2-160). Several of the plasma cell sequences used were 
extensively somatically mutated from corresponding germline alleles, indicative of previous 
antigen exposure. We identified 5 unique phage peptides from 25 phage peptides selected. 
Database searches revealed that they shared sequence homologies with Epstein-Barr nuclear 
antigens 4 and 6, as well as with other human proteins. The specificity of the phage peptides 
to panning MS brain rAbs were confirmed by ELISA. The poly-specific nature of the positive 
peptides binding to rAb A1 (ST-176) was also apparent, contrasting with the monospecific 
nature of the peptides binding to rAb A2 (ST-196) and rAb B1 (G2-160). Variable binding 
affinity to the peptide clones was apparent. In addition, as previously found (Yu, Burgoon, 
2011a), all of the peptide epitopes recognised by the MS brain rAbs were determined to be 
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linear as opposed to conformational. Not all conformational epitopes may be recognised by 
linear phage libraries (Yu, Burgoon, 2011a). This is important as B cell epitopes may be 
linear or conformational.  
 
One of the most significant observations of this study was that functional antibodies can be 
generated from MS autopsy brain by laser capture microdissection, and the peptides 
identified by these brain rAbs were recognized by intrathecal IgG from other MS patients but 
neither paired serum IgG nor control IgG obtained from an inflammatory control. It was then 
important to confirm and extend this binding pattern by demonstrating that the MS brain rAb-
selected peptide was recognized by MS oligoclonal IgG bands. Indeed, the peptides reacted 
with antibody derived from multiple MS patients and supporting the notion that these 
peptides may have functional/disease significance. Such binding peptides have the potential 
to determine the identity of intrathecal IgG in MS (Yu, Gilden, 2011b).  
 
It is important to determine the precise identity of all the peptides and the candidate proteins 
that have been recognised by these rAbs, although we failed to identify any common antigens 
based on database searches with these peptides. We recently reported that peptides identified 
by MS CSF IgG antibodies were patient specific (Graner, Pointon, 2020). Such information is 
likely to give important clues as to corresponding cognate antigens in MS brain that these 
binding peptides may represent, and potentially the causes of the different phenotypes of MS. 
In addition, the lack of common antigens to intrathecal IgG in MS may suggest that other 
functions of these antibodies (effector function) may be more relevant to disease 
pathogenesis. 
It is possible that the heterogeneity of MS patients may be reflected by a corresponding 
heterogeneity in peptides binding to oligoclonal IgG as we have shown (Graner, Pointon, 
2020). While the results described in this study were obtained from a small number of MS 
brain rAbs, RRMS and SPMS represent a diverse population of MS patients to which an 
expanded application of these techniques may be applied. The phage display panning 
technique may identify many different MS-associated peptides, and this approach offers 
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Fig. 1. ELISA demonstrating binding specificities of selected phage peptides to panning 
MS brain rAbs. Phage peptides selected by rAb A1 (ST-176) and rAb A2 (ST-196) were 
amplified and used to determine specificity to panning rAbs by ELISA. Panning rAbs were 
coated onto wells in ELISA plates, followed by addition of corresponding phage and detected 
by HRP-anti M13 antibodies. A. ELISA of phage peptides identified by MS rAb A1 (ST-176) 
A1, C3, E2, B1 were used to determine specificity to panning rAb A1. Positive phage 
peptides to panning MS rAb A1 (ST-176) but not to control human IgG were observed B. 
ELISA showing positive phage peptides to panning MS rAb A2 (ST-196) but not to control 
human IgG. C. Peptides (ST176-C3 and B1) identified by brain rAb A1 (ST-176) were poly-
specific, and peptides (F4 and D2) panned by MS rAb A2 (ST-196) were specific to panning 
rAb, but not to rAb from the same brain (ST-176), nor to control human IgG. D. Dose 
response ELISA confirming binding specificity of phage peptides A2 (ST-196) D2 and F4 to 
panning MS brain rAb A2 (ST-196).  
 
Fig. 2. Western blots showing that phage peptides were reactive to panning MS brain 
rAbs, confirming linearity of phage peptides. Four representative phage peptides selected 
by 2 MS brain rAbs were separated on a gradient of 4-12% SDS polyacrylamide gel, blotted 
to a PVDF membrane and incubated with corresponding MS brain rAbs. Blots of anti-pIII 
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(phage protein) antibody probing with a duplicate membrane (lower panel) are shown as 
positive control. Brain A=rAb A2 (ST-196); Brain B=rAb B1 (G2-160).  
 
Fig. 3. Phage IPCR showing phage peptides selected by MS brain rAb A2 (ST-196) was 
recognized by MS CSF intrathecal IgG, but not by paired serum IgG, nor by an 
inflammatory control CSF IgG. A. Phage peptide A2 (ST-196) F4 (selected by MS brain 
rAb A2) was recognized by a MS CSF, but not by paired serum and human IgG control. B. 
Phage A2 (ST-196) F4 binds with same affinity to inflammatory control CSF (IC07-2, 
chronic progressive meningoencephalitis), serum and human IgG control. C. Phage A2 (ST-
196) C3 was recognized by MS CSF, but not by paired serum and human IgG control. D. 
Phage A2 (ST-196) C3 binds with same affinity to inflammatory control CSF, serum and 
control IgG.  
 
Fig. 4. Phage probed isoelectric focused blots demonstrate that MS brain rAb specific 
peptide was recognized by oligoclonal IgG bands. Paired MS CSF and serum (3–5 μg total 
IgG) from one MS patient and MS brain rAb A2 (ST-196) were resolved on agarose IEF gels 
and transferred to nitrocellulose membranes. The blots were probed with corresponding 
phage peptide A2 (ST-196) F4 (1010 pfu/ml) followed by incubation with mouse anti-pIII 
antibody and detected by AP-anti-mouse antibody (right panel with phage probe). Duplicate 
blot was probed with anti-human IgG as positive controls to reveal oligoclonal bands. Peptide 
selected by MS brain rAb was recognized by multiple high-density oligoclonal IgG bands in 
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